DXCM
DexCom Inc
NASDAQ: DXCM · HEALTHCARE · MEDICAL DEVICES
$57.56
-2.97% today
Updated 2026-04-29
Market cap
$22.21B
P/E ratio
27.54
P/S ratio
4.76x
EPS (TTM)
$2.09
Dividend yield
—
52W range
$54 – $90
Volume
4.1M
DexCom Inc (DXCM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-43.73M | $-33.21M | $-37.45M | $-39.39M | $-42.68M | $-30.13M | $-33.10M | $2.40M | $23.60M | $49.00M | $56.20M | $92.00M | $123.20M | $314.50M | $475.60M | $442.50M | $669.50M | $748.50M | $989.50M | $1.44B |
| Capital expenditures | $3.35M | $3.44M | $2.49M | $2.99M | $6.86M | $8.01M | $9.50M | $7.90M | $16.20M | $33.30M | $55.70M | $66.00M | $67.10M | $180.00M | $199.00M | $389.20M | $364.80M | $236.60M | $358.80M | $363.50M |
| Depreciation | $2.70M | $3.33M | $3.58M | $2.37M | $2.44M | $3.76M | $6.60M | $7.00M | $8.40M | $10.80M | $15.00M | $16.10M | $29.10M | $48.70M | $67.10M | $102.00M | $155.90M | $186.00M | $217.70M | $251.80M |
| Stock-based comp | $5.85B | $6.12M | $7.68M | $8.37M | $9.44M | $13.51M | $18.40M | $24.60M | $50.00M | $82.70M | $110.80M | $106.20M | $101.90M | $102.70M | $119.40M | $113.40M | $126.50M | $150.80M | $170.40M | $159.60M |
| Free cash flow | $-47.09M | $-36.65M | $-39.94M | $-42.38M | $-49.54M | $-38.13M | $-42.60M | $-5.50M | $7.40M | $15.70M | $500000.00 | $26.00M | $56.10M | $134.50M | $276.60M | $53.30M | $304.70M | $511.90M | $630.70M | $1.08B |
| Investing cash flow | $-26.56M | $-8.44M | $24.32M | $-14.10M | $-25.61M | $-46.37M | $28.40M | $20.90M | $-16.80M | $-51.50M | $-55.90M | $-144.40M | $-139.80M | $-1.02B | $-1.02B | $-216.10M | $-521.50M | $-507.20M | $-207.50M | $536.00M |
| Financing cash flow | $51.21M | $46.60M | $2.71M | $44.38M | $69.65M | $74.18M | $10.20M | $11.80M | $21.80M | $16.80M | $8.10M | $399.10M | $710.40M | $10.70M | $912.10M | $10.40M | $-552.50M | $-318.60M | $-734.80M | $-1.69B |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | $1.23B | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-2.34M | $5.50M | $35.10M | $28.60M | $14.30M | $8.40M | $347.00M | $693.80M | $-690.00M | $369.70M | $236.80M | $-404.50M | — | — | — |